Linked Life Data

20586923

Source:http://linkedlifedata.com/resource/pubmed/id/20586923

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-10-28
pubmed:databankReference
pubmed:abstractText
On top of aspirin, an abciximab bolus-only regimen results in a 30% drop in platelet inhibition at 6 h as compared with the on-label regimen. The concomitant administration of high loading dose clopidogrel, by bridging with abciximab bolus, may sustain suppression of platelet activity over time.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1538-7836
pubmed:author
pubmed:copyrightInfo
© 2010 International Society on Thrombosis and Haemostasis.
pubmed:issnType
Electronic
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1903-11
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting.
pubmed:affiliation
Institute of Cardiology, University of Ferrara, Ferrara, Italy. vlgmrc@unife.it
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't